Paydirt
AV
Insider

Adam M Veness

SVP, General Counsel and Sec.

Adam M Veness (SVP, General Counsel and Sec.) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Dianthus Therapeutics, Inc. (DNTH). The largest single filing was $2.4M of DNTH (30,000 sh across 2 lots, as filed), executed Jun 17.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.6M
shares × price, as filed
Last traded
Aug 10
Filed Aug 11

Median ADV $122.5M across their filed names

Open performance
Volume by month
$2.4M$1.2M$0Oct 2024Apr 2025Oct 2025Apr 2026Jun 2026 · sells $2.4MAug 2026 · sells $2.1M
Buys $0 Sells $4.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
DNTH Dianthus Therapeutics, Inc. DNTH · 0 buys · 2 sells 2 filings
Recent filings
DNTHSALE Dianthus Therapeutics, Inc. View filing → $2.1M
19,384 sh across 2 lots
Exec Aug 7
Filed Aug 11 · 5:08 PM ET
DNTHSALE Dianthus Therapeutics, Inc. View filing → $2.4M
30,000 sh across 2 lots
Exec Jun 17
Filed Jun 18 · 5:30 PM ET